Streetbeat News

Analyst Ratings

ACRX

ALLR

HSDT

HSTO

OGN

Benzinga Insights has identified five value stocks in the healthcare sector based on quantified analysis. These include AcelRx Pharmaceuticals (ACRX), Organon (OGN), Histogen (HSTO), Allarity Therapeutics (ALLR), and Helius Medical Tech (HSDT). The companies have shown varying performance in their earnings per share, with some experiencing increases and others decreases.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 2:43 pm

TXG

Morgan Stanley analyst Tejas Savant has reiterated an Overweight rating on 10x Genomics (NASDAQ:TXG) and maintained a $65 price target.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 2:43 pm

MARA

Marathon Digital Holding's stock has been downgraded from Buy to Neutral by Chardan Capital, which maintained its $15 price target. This has resulted in a decrease in the trading value of Marathon's shares.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 2:40 pm

ZG

Barclays analyst Trevor Young maintains an Underweight rating on Zillow Gr (NASDAQ:ZG) and raises the price target from $30 to $36.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 2:38 pm

TSLX

Truist Securities analyst Mark Hughes has maintained a 'Buy' rating on Sixth Street Specialty (NYSE:TSLX) and raised the price target from $20 to $22.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 2:38 pm

XPO

Barclays analyst Brandon Oglenski maintains an Overweight rating on XPO Logistics (NYSE:XPO) and raises the price target from $70 to $76.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 2:37 pm

NGVT

Ingevity Corporation's stock has been downgraded by BMO Capital from Outperform to Market Perform, with a reduced price target from $71 to $80. This has led to a decrease in the trading price of Ingevity shares.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 2:37 pm

SBOW

Truist Securities analyst Neal Dingmann maintains a 'Buy' rating on SilverBow Resources (NYSE:SBOW) and raises the price target from $41 to $51.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 2:36 pm

WLK

Barclays analyst Michael Leithead has maintained an Equal-Weight rating on Westlake (NYSE:WLK) and raised the price target from $130 to $135.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2023 | 2:36 pm

RBC

Truist Securities analyst Michael Ciarmoli maintains a 'Buy' rating on RBC Bearings and raises the price target from $265 to $275.

Portfolio Pulse from richadhand@benzinga.com

August 07, 2023 | 2:35 pm